2. Langlands AO, Kerr GM. Prognosis in breast cancer: the relevance of clinical staging. Clin Radiol 1978;29:599-606.
3. Langlands AO, Gore SM, Kerr GM. Should adjuvant chemotherapy be withheld from any patients with operable breast cancer? An analysis of strategies based on tumor size. Br Med J 1982;285:680-2.
4. Veronesi U, Sacrozzi R, Del Veccho, Banfi A, Clemente C, Lena MD, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11.
5. Adair F, Berg J, Joubert L, Robbings G. Long-term follow-up of breast cancer patients: the 30-year report. Cancer 1974;33:1145-50.
6. Pascual MR, Rodriguez M, Zayas A, Moreno L, Lage A. Factors associated with prognosis in human breast cancer: II. Multivariate stratification analysis. Neoplasma 1983;30:485-92.
7. Peterson AHG, Zuck VP, Szafran O, Lees AW, Hanson J. Influence and significance of certain prognostic factors on survival in breast cancer. Eur J Cancer Clin Oncol 1982;18:937-43.
8. Blamey RW, Davies CJ, Elston CW, Johnson J, Haybittle JL, Maynard PV. Prognostic factors in breast cancer: the formation of a prognostic index. Clin Oncol 1979;5:227-36.
10. Wallgren A, Silfversward C, Eklund G. Prognostic factors in mammary carcinoma. Acta Radiol Ther Phys Biol 1976;15:1-16.
11. Atkinson EN, Brown BW, Montague ED. Tumor volume, nodal status, and metastasis in breast cancer in women. J Natl Cancer Inst 1986;76:171-8.
13. Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004;230:29-41.
14. McCormack VA, Perry N, Vinnicombe SJ, Silva IS. Ethnic variations in mammographic density: a British multiethnic longitudinal study. Am J Epidemiol 2008;168:412-21.
17. Winkler NS, Raza S, Mackesy M, Birdwell RL. Breast density: clinical implications and assessment methods. Radiographics 2015;35:316-24.
18. Huay-Ben P. The role of breast ultrasound in early cancer detection. J Med Ultrasound 2016;24:138-41.
19. Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999;17:460-9.
20. van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902. J Clin Oncol 2001;19:4224-37.
22. Gonzalez V, Sandelin K, Karlsson A, Åberg W, Löfgren L, Iliescu G, et al. Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 2014;38:1685-93.
23. Yang WT, Lam WW, Cheung H, Suen M, King WW, Metreweli C. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 1997;16:791-7.
24. Cheung YC, Wan YL, Lo YF, Leung WM, Chen SC, Hsueh S. Preoperative magnetic resonance imaging evaluation for breast cancers after sonographically guided core-needle biopsy: a comparison study. Ann Surg Oncol 2004;11:756-61.
25. Hwang KT, Kim HY, Chung JK, Jung IM, Heo SC, Ahn YJ, et al. A comparative study between the preoperative diagnostic tumor size and the postoperative pathologic tumor size in patients with breast tumors. J Breast Cancer 2010;13:187-97.
26. Musaed R, Jai MR, Jeong EL, Mansour A, Bookyung H, Ha WY, et al. Preoperative breast magnetic resonance imaging for the assessment of the size of ductal carcinoma in situ. J Breast Dis 2016;4:77-84.
27. Kang DK, Jeon GS, Yim H, Jung YS. Diagnosis of the intraductal component of invasive breast cancer: assessment with mammography and sonography. J Ultrasound Med 2007;26:1587-600.
28. Fornage BD, Toubas O, Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 1987;60:765-71.